Adverse effects of delta‐9‐tetrahydrocannabinol on sickle red blood cells

Aline Hatem (1, 2) , Sofia Esperti (3, 2, 4) , Nicoletta Murciano (5, 6) , Min Qiao (6, 7) , Maria Giustina Rotordam (5) , Nadine Becker (5) , Elie Nader (3, 2) , Felix Maurer (7) , Laurent Pérès (1, 2) , Guillaume Bouyer (1, 2) , Lars Kaestner (8) , Philippe Connes (3, 2) , Stéphane Egée (1, 2)

1 LBI2M - Laboratoire de Biologie Intégrative des Modèles Marins
2 Labex Gr-Ex - Laboratoire d'Excellence : Biogenèse et pathologies du globule rouge
3 LIBM - Laboratoire Interuniversitaire de Biologie de la Motricité
4 ERYTECH Pharma
5 Nanion Technologies
6 Theoretical Medicine and Biosciences, Saarland University
7 Experimental Physics, Saarland University,
8 Saarland University [Saarbrücken]

Domaines: Sciences du Vivant [q-bio]

Aline Hatem, Sofia Esperti, Nicoletta Murciano, Min Qiao, Maria Giustina Rotordam, et al.. Adverse effects of delta‐9‐tetrahydrocannabinol on sickle red blood cells. American Journal of Hematology, 2023, 98 (12), ⟨10.1002/ajh.27109⟩. ⟨hal-04409684⟩